Cardiometabolic Health Intervention Using Movement-to-Music Exercise (CHIME)

May 6, 2026 updated by: Jereme Wilroy, University of Alabama at Birmingham

Examining the Effects of Live Telehealth Exercise Training on Cardiometabolic Outcomes in Wheelchair Users

The study aims to test the benefits of a 24-week, cardio-emphasized Movement-to-Music exercise program for reversing cardiometabolic health risk factors compared to asynchronous, standard exercise programs among 132 adult wheelchair users. The targeted cardiometabolic health factors are waist circumference, triglycerides, "good" cholesterol, glucose, and blood pressure. Additionally, a 12-week follow-up phase (weeks 25-36) is included to see whether the gains are maintained.

Study Overview

Detailed Description

Baseline Assessment: Participants will be asked to complete a baseline assessment. This measures physical health (e.g., cardiometabolic health factors, fat/muscle mass) and functions (e.g., muscular strength, aerobic endurance) and a series of self-reported questionnaires that are related to participant's demographics, psychosocial health (depression, sleep, fatigue), quality of life, and physical activity behaviors (volume of activity). The onsite physical tests will take approximately 2 hours to complete. The questionnaires will be completed electronically and may take up to an hour. The assessments are listed below.

PHYSICAL TEST: The physical tests will take place (1) at the UAB Research Collaborative Center (3810 Ridgeway Dr. Birmingham, AL 35209) and (2) at Lakeshore Foundation's human performance lab (4000 Ridgeway Dr. Birmingham, AL 35209).

  1. Blood draw
  2. Anthropometrics (weight, height, waist circumference)
  3. Body composition (amount of fat mass and fat free mass) by dual x-ray absorptiometry (DXA): DXA scans will be performed to measure any changes in fat-mass and fat-free mass. X-ray scans will be performed on 3 occasions using an iDXA whole-body scanner (GE-Lunar Radiation Corporation, Madison, WI). The radiation dose is less than 1 mrem. Scans will be analyzed using CoreScan software, and muscle mass will be estimated using published equations. Trained lab staff will be available to assist with transitioning from the wheelchair to the scan platform and back again.
  4. Hand grip strength: Hand-held dynamometer will be used to measure any changes in grip strength.
  5. Aerobic endurance by an arm-crank ergometer and open-circuit spirometry system: Open-circuit spirometry system will be used to measure any changes in heart rate, rate of perceived exertion (i.e., how much effort you feel you are giving), and amount of air you can breathe out while performing a 20-minute, continuous arm-crank ergometer.
  6. Lung strength by spirometer: Spirometer will be used to measure how much air you exhale and how quickly you exhale. You will take a deep breath and breathe out as hard as you can for several seconds into the tube.

QUESTIONNAIRES:

  1. Leisure Time Physical Activity Questionnaire for Spinal Cord Injury
  2. NIH PROMIS Pain Intensity Short Form
  3. NIH PROMIS Pain Interference Short Form
  4. NIH PROMIS Fatigue Short Form
  5. NIH PROMIS Sleep Disturbance Short Form
  6. NIH PROMIS 10 Global Health Items
  7. NIH PROMIS Ability to Participate in Social Roles and Activities
  8. NIH PROMIS Depression Short Form
  9. NIH PROMIS Anxiety Short Form
  10. NIH PROMIS Physical Function Form
  11. Exercise Self-efficacy Scale
  12. Exercise Goal-setting and Planning Scale
  13. Demographics and Health History Questionnaire
  14. Rapid Eating Assessment for Participants Shortened Version

Upon completing a baseline assessment, participants will be randomly assigned to one of two groups using a computer-generated code.

Group 1: Instructor-led, one-on-one exercise group (Movement-to-Music [M2M] group) Group 2: Self-guided control with pre-recorded exercise videos

Group 1: For Instructor-led, one-on-one M2M exercise group, participants will be asked to participate in 3 exercise sessions per week for 24 weeks. Each session will last from 25 minutes up to 50 minutes. Increasing by 5 to 10 minutes each week. The exercise program will focus on improving cardiorespiratory fitness using a series of movement patterns accompanied by music. The program will be tailored to individuals' abilities (e.g., use of arms only vs. truck movement together; slow vs. fast tempo music). The exercise will be prescribed at a moderate intensity level (working somewhat hard with increased heart rate and breathing rate), which will be monitored through a wearable heart rate monitor and a custom-designed, secured online application with a personal username and password. All study equipment will be provided, including a computer tablet, tablet stand, and heart rate monitor.

Data collected by the application includes exercise minutes and heart rate. For the first 8 weeks (weeks 1-8), participants will exercise 3 sessions with M2M instructors or assistant health coaches. For the second 8 weeks (weeks 9-16), participants will exercise 2 sessions with M2M instructors or assistant health coaches and 1 session by himself/herself. The first sessions of each week you attend with M2M instructors will be video-recorded and later uploaded to a private cloud. The video-recorded sessions will be used when exercising with and without assistant health coaches. For the third 8 weeks (weeks 17-24), participants will exercise 1 session with assistant health coaches and 2 sessions by himself/herself.

Upon completing the 24-week program, you will receive the recorded exercise sessions between you and the M2M instructors to continue to exercise for the remaining 12 weeks (weeks 25-36).

Group 2: For self-guided control group, you will receive a tablet, tablet stand, and a series of pre-recorded exercise videos for 36 weeks. The videos include warm-up, flexibility, muscular strength, aerobic endurance, balance, and cool-down. Participants will receive a computer tablet and tablet stand.

12-week & 24-week Follow-up Assessments: At the end of the 12- and 24-week, participants will be asked to complete the same set of physical tests and questionnaires you completed at the beginning of the study. At the end of the 36-week, participants will also be asked to complete the same questionnaires with 2 additional surveys regarding the intervention quality, which are listed below.

QUESTIONNAIRES:

15) Physical Activity Enjoyment Scale 16) 5-star rating scale about M2M Instructors (M2M group only) or pre-recorded videos (Control group only)

At the end of the 12- and 24-week study period, participants will be contacted by phone for a brief interview. This interview is to gain information about participation in the program, such as positive and negative experiences. This call will be recorded for data analysis purposes. This interview process will be conducted for only 25% of participants (n=33) for the continuous program content and delivery process improvements.

Study Type

Interventional

Enrollment (Estimated)

132

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

    • Alabama
      • Birmingham, Alabama, United States, 35294
        • Recruiting
        • The University of Alabama at Birmingahm
        • Contact:
        • Principal Investigator:
          • Jereme Wilroy, PhD
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 89 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  1. full-time or part-time use of a wheelchair device (manual wheelchair, power wheelchair, electric scooter) self-reported as the primary means of mobility
  2. ≥ 2 cardiometabolic risk factor(s),
  3. no contraindication to exercise as approved by a physician's medical clearance to exercise
  4. age ≥18 years
  5. able to use arms to exercise
  6. obtaining < 90 minutes of moderate-intensity aerobic exercise per week in the last month
  7. not enrolled in a structured exercise program in the past 6 months
  8. able to converse and read in English.

Exclusion Criteria:

  1. medically unstable to perform home exercise as determined by their physician
  2. high-level tetraplegia and unable to use arms to exercise
  3. no internet access was determined via self-report and internet speed test.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Group 1
Instructor-led, one-on-one M2M exercise group
Participants will attend 3 exercise sessions per week for 24 weeks. Each session will last 15 - 40 minutes. Increasing by 5 - 10 minutes each week. Each session will last from 25 to 50 minutes by increasing 5 to 10 minutes each week. The exercise program will focus on improving cardiorespiratory fitness using a series of movement patterns accompanied by music. The program will be tailored to individuals' abilities (e.g., use of arms only vs. truck movement together; slow vs. fast tempo music). The exercise will be prescribed at a moderate intensity level (working somewhat hard with increased heart rate and breathing rate). For the follow-up phase (weeks 25-36), participants will receive the recorded M2M exercise sessions between the M2M instructors and themselves to continue to exercise for the remaining 12 weeks.
Active Comparator: Group 2
Self-guided control with pre-recorded standard exercise videos
Participants will exercise for 36 weeks using pre-recorded exercise videos. The videos include warm-up, flexibility, muscular strength, aerobic endurance, balance, and cool-down.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Cardiometabolic indicators - hsCRP
Time Frame: Baseline
Blood test Sphygmomanometer
Baseline
Cardiometabolic indicators - HbA1C
Time Frame: Baseline
Blood test Sphygmomanometer
Baseline
Cardiometabolic indicators - fasting insulin
Time Frame: Baseline
Blood test SphygmomanometerSphygmomanometer
Baseline
Cardiometabolic indicators - triglycerides
Time Frame: Baseline
Blood test Sphygmomanometer
Baseline
Cardiometabolic indicators - cholesterol
Time Frame: Baseline
Blood test Sphygmomanometer
Baseline
Cardiometabolic indicators - hsCRP
Time Frame: 12 Weeks
Blood test Sphygmomanometer
12 Weeks
Cardiometabolic indicators - HbA1C
Time Frame: 12 Weeks
Blood test Sphygmomanometer
12 Weeks
Cardiometabolic indicators - fasting insulin
Time Frame: 12 Weeks
Blood test Sphygmomanometer
12 Weeks
Cardiometabolic indicators - triglycerides
Time Frame: 12 Weeks
Blood test Sphygmomanometer
12 Weeks
Cardiometabolic indicators - cholesterol
Time Frame: 12 Weeks
Blood test Sphygmomanometer
12 Weeks
Cardiometabolic indicators - hsCRP
Time Frame: 24 Weeks
Blood test Sphygmomanometer
24 Weeks
Cardiometabolic indicators - HbA1C
Time Frame: 24 Weeks
Blood test Sphygmomanometer
24 Weeks
Cardiometabolic indicators - fasting insulin
Time Frame: 24 Weeks
Blood test Sphygmomanometer
24 Weeks
Cardiometabolic indicators - triglycerides
Time Frame: 24 Weeks
Blood test Sphygmomanometer
24 Weeks
Cardiometabolic indicators - cholesterol
Time Frame: 24 Weeks
Blood test Sphygmomanometer
24 Weeks
Body composition - Waist Circumference
Time Frame: Baseline
Measurement of waist size
Baseline
Body composition - Waist Circumference
Time Frame: 12 Weeks
Measurement of waist size
12 Weeks
Body composition - Waist Circumference
Time Frame: 24 Weeks
Measurement of waist size
24 Weeks
Cardiometabolic indicators - glucose
Time Frame: Baseline
Blood test Sphygmomanometer
Baseline
Cardiometabolic indicators - glucose
Time Frame: 12 Weeks
Blood test Sphygmomanometer
12 Weeks
Body composition - DEXA
Time Frame: Baseline
Dual energy X-ray absorptiometry
Baseline
Body composition - DEXA
Time Frame: 12 Weeks
Dual energy X-ray absorptiometry
12 Weeks
Body composition - DEXA
Time Frame: 24 Weeks
Dual energy X-ray absorptiometry
24 Weeks
Body composition - Weight
Time Frame: baseline
participants weight
baseline
Body composition - Weight
Time Frame: 12 weeks
participants weight
12 weeks
Body composition - Weight
Time Frame: 24 weeks
participants weight
24 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Cardiovascular capacity - Open-circuit spirometry system (ParvoMedics TrueOne 2400)
Time Frame: Baseline
Open-circuit spirometry system (ParvoMedics TrueOne 2400)
Baseline
Cardiovascular capacity - Open-circuit spirometry system (ParvoMedics TrueOne 2400)
Time Frame: 12 Weeks
Open-circuit spirometry system (ParvoMedics TrueOne 2400)
12 Weeks
Cardiovascular capacity - Open-circuit spirometry system (ParvoMedics TrueOne 2400)
Time Frame: 24 Weeks
Open-circuit spirometry system (ParvoMedics TrueOne 2400)
24 Weeks
Cardiovascular capacity - Polar heart rate monitor
Time Frame: Baseline
Polar heart rate monitor
Baseline
Cardiovascular capacity - Polar heart rate monitor
Time Frame: 12 Weeks
Polar heart rate monitor
12 Weeks
Cardiovascular capacity - Polar heart rate monitor
Time Frame: 24 Weeks
Polar heart rate monitor
24 Weeks
Pulmonary function
Time Frame: Baseline
Spirometry (forced expiratory volume over 1 second; forced vital capacity)
Baseline
Pulmonary function
Time Frame: 12 Weeks
Spirometry (forced expiratory volume over 1 second; forced vital capacity)
12 Weeks
Pulmonary function
Time Frame: 24 Weeks
Spirometry (forced expiratory volume over 1 second; forced vital capacity)
24 Weeks
Physical activity
Time Frame: Baseline
Complete LTPAQ-SCI online survey
Baseline
Physical activity
Time Frame: 12 Weeks
Complete LTPAQ-SCI online survey
12 Weeks
Physical activity
Time Frame: 24 Weeks
Complete LTPAQ-SCI online survey
24 Weeks
Physical activity
Time Frame: 36 Weeks
Complete LTPAQ-SCI online survey
36 Weeks
Cardiovascular capacity - Borg CR10 RPE Scale
Time Frame: Baseline
Borg RPE Scale
Baseline
Cardiovascular capacity - Borg CR10 RPE Scale
Time Frame: 12 Weeks
Borg RPE Scale
12 Weeks
Cardiovascular capacity - Borg CR10 RPE Scale
Time Frame: 24 Weeks
Borg RPE Scale
24 Weeks
Muscle strength
Time Frame: Baseline
Hand-held grip strength (kg)
Baseline
Muscle strength
Time Frame: 12 Weeks
Hand-held grip strength (kg)
12 Weeks
Muscle strength
Time Frame: 24 Weeks
Hand-held grip strength (kg)
24 Weeks
Physical health
Time Frame: Baseline
Complete NIH PROMIS online surveys
Baseline
Physical health
Time Frame: 12 Weeks
Complete NIH PROMIS online surveys
12 Weeks
Physical health
Time Frame: 24 Weeks
Complete NIH PROMIS online surveys
24 Weeks
Physical health
Time Frame: 36 Weeks
Complete NIH PROMIS online surveys
36 Weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Jereme Wilroy, PhD, The University of Alabama at Birmingham

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 11, 2023

Primary Completion (Estimated)

August 30, 2027

Study Completion (Estimated)

December 30, 2027

Study Registration Dates

First Submitted

October 31, 2022

First Submitted That Met QC Criteria

October 31, 2022

First Posted (Actual)

November 4, 2022

Study Record Updates

Last Update Posted (Actual)

May 8, 2026

Last Update Submitted That Met QC Criteria

May 6, 2026

Last Verified

May 1, 2026

More Information

Terms related to this study

Other Study ID Numbers

  • IRB-300009718
  • 5R01HD111059 (U.S. NIH Grant/Contract)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cardiometabolic Risk Factors in Adult Wheelchair Users

Clinical Trials on Instructor-led, one-on-one M2M exercise group

Subscribe